Hudson Valley Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7M Sell
41,468
-1,370
-3% -$1.4M 6.04% 1
2026
Q1
$39.4M Sell
42,838
-2,656
-6% -$2.69M 5.11% 2
2025
Q4
$48.9M Sell
45,494
-2,482
-5% -$2.37M 5.41% 1
2025
Q3
$36.6M Sell
47,976
-51
-0.1% -$38K 3.81% 4
2025
Q2
$37.4M Sell
48,027
-145
-0.3% -$113K 4.1% 4
2025
Q1
$39.8M Sell
48,172
-59
-0.1% -$49.1K 4.75% 2
2024
Q4
$37.2M Sell
48,231
-85
-0.2% -$70.4K 4.22% 3
2024
Q3
$42.8M Sell
48,316
-4,204
-8% -$3.78M 4.74% 1
2024
Q2
$32.9M Buy
52,520
+1,129
+2% +$903K 4.27% 2
2024
Q1
$40M Buy
51,391
+1,101
+2% +$784K 4.79% 1
2023
Q4
$31.5M Sell
50,290
-1,493
-3% -$871K 4.31% 2
2023
Q3
$27.8M Sell
51,783
-610
-1% -$314K 3.92% 2
2023
Q2
$24.6M Sell
52,393
-1,982
-4% -$831K 3.33% 3
2023
Q1
$18.7M Buy
54,375
+762
+1% +$257K 2.61% 7
2022
Q4
$19.6M Sell
53,613
-1,552
-3% -$550K 2.97% 5
2022
Q3
$17.8M Sell
55,165
-225
-0.4% -$71.3K 2.86% 6
2022
Q2
$18M Sell
55,390
-530
-0.9% -$159K 2.8% 6
2022
Q1
$16M Buy
55,920
+63
+0.1% +$16.2K 2.15% 12
2021
Q4
$15.4M Sell
55,857
-518
-0.9% -$131K 2.41% 10
2021
Q3
$13M Sell
56,375
-1,078
-2% -$266K 2.23% 13
2021
Q2
$13.2M Sell
57,453
-2,087
-4% -$419K 2.29% 11
2021
Q1
$11.1M Sell
59,540
-1,650
-3% -$323K 1.99% 14
2020
Q4
$10.3M Buy
61,190
+1,307
+2% +$195K 1.97% 13
2020
Q3
$8.86M Buy
59,883
+120
+0.2% +$18.6K 1.91% 12
2020
Q2
$9.81M Buy
59,763
+198
+0.3% +$30.4K 2.28% 9
2020
Q1
$8.26M Sell
59,565
-7,799
-12% -$1.07M 2.29% 9
2019
Q4
$8.85M Buy
67,364
+1,443
+2% +$167K 1.89% 10
2019
Q3
$7.37M Buy
65,921
+550
+0.8% +$61.2K 1.71% 13
2019
Q2
$7.24M Buy
65,371
+6,083
+10% +$716K 1.68% 13
2019
Q1
$7.69M Sell
59,288
-15
-0% -$1.82K 1.86% 11
2018
Q4
$6.86M Buy
59,303
+1,368
+2% +$153K 1.58% 17
2018
Q3
$6.22M Buy
57,935
+132
+0.2% +$13.2K 1.44% 19
2018
Q2
$4.93M Buy
57,803
+1,255
+2% +$103K 1.21% 26
2018
Q1
$4.38M Buy
56,548
+165
+0.3% +$13.3K 1.1% 30
2017
Q4
$4.76M Buy
56,383
+435
+0.8% +$37K 1.18% 28
2017
Q3
$4.79M Buy
55,948
+390
+0.7% +$32K 1.24% 22
2017
Q2
$4.57M Buy
55,558
+270
+0.5% +$22K 1.26% 23
2017
Q1
$4.65M Sell
55,288
-1,155
-2% -$92.5K 1.3% 23
2016
Q4
$4.15M Buy
56,443
+508
+0.9% +$37.8K 1.22% 23
2016
Q3
$4.49M Buy
55,935
+585
+1% +$46.8K 1.39% 20
2016
Q2
$4.36M Buy
55,350
+287
+0.5% +$21.6K 1.4% 19
2016
Q1
$3.96M Buy
55,063
+75
+0.1% +$5.67K 1.29% 23
2015
Q4
$4.63M Sell
54,988
-11,260
-17% -$934K 1.44% 17
2015
Q3
$5.54M Sell
66,248
-187
-0.3% -$15.8K 1.8% 12
2015
Q2
$5.55M Buy
66,435
+35,190
+113% +$2.68M 1.73% 13
2015
Q1
$2.27M Buy
31,245
+23,565
+307% +$1.68M 0.77% 47
2014
Q4
$530K Buy
7,680
+1,018
+15% +$68.7K 0.22% 83
2014
Q3
$432K Buy
6,662
+686
+11% +$43.4K 0.18% 85
2014
Q2
$372K Sell
5,976
-923
-13% -$55.1K 0.16% 91
2014
Q1
$406K Buy
6,899
+187
+3% +$10.4K 0.17% 89
2013
Q4
$342K Buy
6,712
+542
+9% +$27.1K 0.15% 97
2013
Q3
$311K Sell
6,170
-1,542
-20% -$80.7K 0.15% 100
2013
Q2
$379K Buy
+7,712
New +$420K 0.18% 89

Other funds holding LLY

Hudson Valley Investment Advisors's LLY Position: Q2 2026 in Review

Hudson Valley Investment Advisors reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $1.4M and leaving 41,468 shares worth $49.7M. The position accounts for 6.04% of the portfolio, ranked #1.

Hudson Valley Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hudson Valley Investment Advisors held 41,468 shares of Eli Lilly worth $49.7M as of Q2 2026.
  • Hudson Valley Investment Advisors sold 1,370 Eli Lilly shares in Q2 2026, an estimated $1.4M.
  • Eli Lilly made up 6.04% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #1 holding.
  • Hudson Valley Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.